
UNH
- Market cap
- $472B
- Sector
- Health care

Bought $104M · sold $0
No sale outside a pre-arranged plan
No sale under a plan
Last: Stephen J. Hemsley, $79.9M, 25 Aug 2026
2 insiders bought or sold UNH. One line a Form 4.
| Insider | Role | Side | Value | Shares | Price | Traded | Filed | Lag | Form |
|---|---|---|---|---|---|---|---|---|---|
| Stephen J. Hemsley | CEO | $4.14M | 8,000 | $517.78 | 25 Aug 2026 | 27 Aug 2026 | 2 d | — | |
| Stephen J. Hemsley | CEO | $10.2M | 20,000 | $512.20 | 7 Aug 2026 | 11 Aug 2026 | 4 d | — | |
| Stephen J. Hemsley | CEO | $6.16M | 12,000 | $513.21 | 30 Jul 2026 | 31 Jul 2026 | 1 d | — | |
| Stephen J. Hemsley | CEO | $12.4M | 20,000 | $622.09 | 10 Apr 2026 | 13 Apr 2026 | 3 d | — | |
| Stephen J. Hemsley | CEO | $13.0M | 20,000 | $649.15 | 20 Mar 2026 | 24 Mar 2026 | 4 d | — | |
| Stephen J. Hemsley | CEO | $21.5M | 35,000 | $615.46 | 24 Nov 2025 | 26 Nov 2025 | 2 d | — | |
| Stephen J. Hemsley | CEO | $12.4M | 20,000 | $620.03 | 6 Oct 2025 | 8 Oct 2025 | 2 d | — | |
| John Rex | President and CFO | $4.72M | 9,000 | $524.76 | 17 Jun 2026 | 19 Jun 2026 | 2 d | — | |
| John Rex | President and CFO | $2.39M | 4,500 | $531.82 | 5 Jun 2026 | 9 Jun 2026 | 4 d | — | |
| John Rex | President and CFO | $5.92M | 9,000 | $657.48 | 3 Feb 2026 | 5 Feb 2026 | 2 d | — | |
| John Rex | President and CFO | $5.68M | 9,000 | $630.72 | 19 Dec 2025 | 22 Dec 2025 | 3 d | — | |
| John Rex | President and CFO | $5.71M | 9,000 | $634.42 | 28 Nov 2025 | 1 Dec 2025 | 3 d | — |
Open-market purchases against sales, in dollars. The bar is the person's balance against the largest balance on the page: right is net buying, left net selling.
| Insider | Role | Bought | Sold | Net flow |
|---|---|---|---|---|
| Stephen J. Hemsley | CEO · 7 purchases in 7 filings | $79.9M | $0 | +$79.9M |
| John Rex | President and CFO · 5 purchases in 5 filings | $24.4M | $0 | +$24.4M |
One marker a filing: a purchase up, a sale at the insider's discretion down, a pre-planned sale grey. Select a marker for its figures.
The series read here does not reach back this far.
UNH closed at $692.7 on 2025-09-09 and $512.6 on 2026-09-09. Drawn as a line of daily closes. 12 marked trades in this range: Stephen J. Hemsley: purchase, 25 Aug 2026; Stephen J. Hemsley: purchase, 7 Aug 2026; Stephen J. Hemsley: purchase, 30 Jul 2026; John Rex: purchase, 17 Jun 2026; John Rex: purchase, 5 Jun 2026; Stephen J. Hemsley: purchase, 10 Apr 2026; Stephen J. Hemsley: purchase, 20 Mar 2026; John Rex: purchase, 3 Feb 2026; John Rex: purchase, 19 Dec 2025; John Rex: purchase, 28 Nov 2025; Stephen J. Hemsley: purchase, 24 Nov 2025; Stephen J. Hemsley: purchase, 6 Oct 2025.
Every 13F figure is of the last complete quarter — one whose 45-day deadline has passed, rolled to the next business day — never of a quarter still filing. That is Q2 2026, due 14 Aug 2026.
Institutional ownership is an estimate: the quarter's whole reported value, less its option lines at the quarter's own price, over the company's value at that price and today's share count. A manager that files for an affiliate as well can be counted twice, so it can run high.
Each event starts from a weight — an insider's open-market purchase 100 (×1.5 for an officer, ×0.5 under a plan), several insiders buying within weeks 90, the CEO's discretionary sale of $1 million or more 90 (another top officer's 60), a super investor's new position 60 (×1.5 at 1% or more of the portfolio), an exit 50, a move of a quarter or more 40 (×1.25 at 2% or more of the portfolio), institutions' net of 1% of the shares 50 or holders up or down 5% 40, and a member's five or more reports, or one of $50,001 or more, 30 — and loses weight with age, down to half after six months. The five strongest are shown, larger amounts first on a tie; where pre-planned sales are most of what insiders sold, the four strongest are shown and one more line says so.
Why purchases weigh most: studies of insider trading find that purchases carry the information and sales mostly do not, that pre-arranged and routine trades carry none, and that a fund's largest weights are its strongest views. Studies of members' trades find no consistent outperformance.